Combined therapy with oncolytic adenoviruses encoding TRAIL and IL-12 genes markedly suppressed human hepatocellular carcinoma both in vitro and in an orthotopic transplanted mouse model
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Combined therapy with oncolytic adenoviruses encoding TRAIL and IL-12 genes markedly suppressed human hepatocellular carcinoma both in vitro and in an orthotopic transplanted mouse model
Authors
Keywords
Dual gene virotherapy, Oncolytic adenoviruses, Interleukin-12, Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), Hepatocellular carcinoma
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 35, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-05-06
DOI
10.1186/s13046-016-0353-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Systemic PEGylated TRAIL treatment ameliorates liver cirrhosis in rats by eliminating activated hepatic stellate cells
- (2016) Yumin Oh et al. HEPATOLOGY
- CD146 promotes metastasis and predicts poor prognosis of hepatocellular carcinoma
- (2016) Guoqing Jiang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The Efficacy of Continued Sorafenib Treatment after Radiologic Confirmation of Progressive Disease in Patients with Advanced Hepatocellular Carcinoma
- (2016) Yoshiyuki Wada et al. PLoS One
- Targeting adeno-associated virus and adenoviral gene therapy for hepatocellular carcinoma
- (2016) Yi-Gang Wang WORLD JOURNAL OF GASTROENTEROLOGY
- Safety and antitumor effect of oncolytic and helper-dependent adenoviruses expressing interleukin-12 variants in a hamster pancreatic cancer model
- (2015) J Poutou et al. GENE THERAPY
- Potent and long-term antiangiogenic efficacy mediated by FP3-expressing oncolytic adenovirus
- (2015) Il-Kyu Choi et al. INTERNATIONAL JOURNAL OF CANCER
- Oncolytic Newcastle disease virus expressing chimeric antibody enhanced anti-tumor efficacy in orthotopic hepatoma-bearing mice
- (2015) Ding Wei et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Progress in clinical oncolytic virus-based therapy for hepatocellular carcinoma
- (2015) Adel H. Jebar et al. JOURNAL OF GENERAL VIROLOGY
- Going viral: a review of replication-selective oncolytic adenoviruses
- (2015) Christopher Larson et al. Oncotarget
- Interleukin 12: still a promising candidate for tumor immunotherapy?
- (2014) Witold Lasek et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- New insights into IL-12-mediated tumor suppression
- (2014) S Tugues et al. CELL DEATH AND DIFFERENTIATION
- Getting TRAIL back on track for cancer therapy
- (2014) J Lemke et al. CELL DEATH AND DIFFERENTIATION
- Adenovirus Vectors for Gene Therapy, Vaccination and Cancer Gene Therapy
- (2014) William Wold et al. CURRENT GENE THERAPY
- Oncolytic Viruses as Anticancer Vaccines
- (2014) Norman Woller et al. Frontiers in Oncology
- TRAIL negatively regulates VEGF-induced angiogenesis via caspase-8-mediated enzymatic and non-enzymatic functions
- (2013) Hee-Jun Na et al. ANGIOGENESIS
- Recent advances in delivery of drug–nucleic acid combinations for cancer treatment
- (2013) Jing Li et al. JOURNAL OF CONTROLLED RELEASE
- Oncolytic viruses as therapeutic cancer vaccines
- (2013) David L Bartlett et al. Molecular Cancer
- IL-27 Enhances the Expression of TRAIL and TLR3 in Human Melanomas and Inhibits Their Tumor Growth in Cooperation with a TLR3 Agonist Poly(I:C) Partly in a TRAIL-Dependent Manner
- (2013) Yukino Chiba et al. PLoS One
- Dendritic Cells in the Cancer Microenvironment
- (2013) Yang Ma et al. Journal of Cancer
- Synergistic antitumor effect of TRAIL and IL-24 with complete eradication of hepatoma in the CTGVT-DG strategy
- (2012) Y. Cai et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Activated monocytes augment TRAIL-mediated cytotoxicity by human NK cells through release of IFN-γ
- (2012) Dhifaf Sarhan et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- A conditionally replicating adenovirus carrying interleukin-24 sensitizes melanoma cells to radiotherapy via apoptosis
- (2012) Guan Jiang et al. Molecular Oncology
- New frontiers in promoting tumour cell death: targeting apoptosis, necroptosis and autophagy
- (2012) J S Long et al. ONCOGENE
- Evolution of oncolytic adenovirus for cancer treatment
- (2011) Joung-Woo Choi et al. ADVANCED DRUG DELIVERY REVIEWS
- Active targeting of RGD-conjugated bioreducible polymer for delivery of oncolytic adenovirus expressing shRNA against IL-8 mRNA
- (2011) Jaesung Kim et al. BIOMATERIALS
- Gene-viro-therapy targeting liver cancer by a dual-regulated oncolytic adenoviral vector harboring IL-24 and TRAIL
- (2011) X Liu et al. CANCER GENE THERAPY
- Advances in Viral Vector-Based TRAIL Gene Therapy for Cancer
- (2011) Lyse Norian et al. Cancers
- A Hypoxia- and -Fetoprotein-Dependent Oncolytic Adenovirus Exhibits Specific Killing of Hepatocellular Carcinomas
- (2010) O.-J. Kwon et al. CLINICAL CANCER RESEARCH
- Oncolytic Adenoviruses for the Treatment of Human Cancer: Focus on Translational and Clinical Data
- (2010) Sari Pesonen et al. MOLECULAR PHARMACEUTICS
- Therapeutic and Tumor-specific Immunity Induced by Combination of Dendritic Cells and Oncolytic Adenovirus Expressing IL-12 and 4-1BBL
- (2009) Jing-Hua Huang et al. MOLECULAR THERAPY
- Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients
- (2008) Lun Cai et al. CLINICAL IMMUNOLOGY
- Short hairpin RNA-expressing oncolytic adenovirus-mediated inhibition of IL-8: effects on antiangiogenesis and tumor growth inhibition
- (2008) J Y Yoo et al. GENE THERAPY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started